A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. (Q30426497)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. |
scientific article |
Statements
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects (English)
H Czajka
S Unal
S Ulusoy
G Usluer
A Strus
E Sennaroglu
J Guzik
A Topeli Iskit
A Dargiewicz
D Musial
R Caylan
J Dziduch
E Eskioglu
B Hasiec
E Cwinarowiczliwa
R Belli
I A Abdel-Messih
J Beygo
1 September 2012